Latest news with #Dr.Reddy'sLaboratories
New Indian Express
5 days ago
- Business
- New Indian Express
Equity markets close in the red on Tuesday amid losses in financial, oil & gas stocks
CHENNAI: Indian equity markets closed in the red on Tuesday, with the BSE Sensex falling by 212.85 points (0.26%) to settle at 81,583.30, while the NSE Nifty 50 declined by 93.10 points (0.37%) to end at 24,853.40. The downturn was primarily driven by declines in financial and oil & gas stocks, coupled with escalating geopolitical tensions between Israel and Iran, which heightened market uncertainty. The pharma and metal sectors witnessed significant selling pressure. In the pharma space, stocks like Sun Pharma and Dr. Reddy's Laboratories fell over 2%, amid concerns over potential tariffs and trade tensions. The metal sector also registered losses, further contributing to the market's weakness. In contrast, the IT sector bucked the broader trend, with major stocks such as Tech Mahindra and Infosys posting gains. Defence stocks also outperformed, with companies like Mazagon Dock and GRSE gaining over 2%.
Business Upturn
5 days ago
- Business
- Business Upturn
Nifty 50 top losers today, June 17: Adani Enterprises, Dr. Reddy's, Tata Motors, Sun Pharma lead declines
Indian equity benchmarks closed lower on Tuesday, June 17, 2025, as cautious market sentiment weighed on investor confidence. The BSE Sensex dropped 212.85 points (0.26%) to settle at 81,583.30, while the NSE Nifty 50 declined 93.10 points (0.37%), closing at 24,853.40. Several major Nifty 50 stocks saw pressure, dragging the indices lower. Among the biggest losers of the day were well-known names like Adani Enterprises, Eternal and Dr. Reddy's Laboratories. Let's take a closer look at the top losers of the Nifty 50, according to Trendlyne. Nifty 50 top losers on June 17 Adani Enterprises closed at ₹2,485.20, down 2.3%. Eternal ended at ₹247.00, falling 2.1%. Dr. Reddy's Laboratories settled at ₹1,319.90, down 2.0%. Tata Motors closed at ₹673.00, down 2.0%. Sun Pharmaceutical Industries ended at ₹1,653.10, slipping 1.9%. Oil and Natural Gas Corporation (ONGC) closed at ₹252.00, down 1.9%. Shriram Finance finished at ₹663.90, losing 1.8%. Cipla closed at ₹1,503.90, down 1.5%. Bajaj Finance ended at ₹924.00, down 1.5%. Jio Financial Services settled at ₹289.80, falling 1.5%. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Adani enterprisesDr Reddy'sNiftyStock MarketSun PharmaTata Motors Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
6 days ago
- Business
- Business Upturn
Nifty 50 top losers today, June 16: Tata Motors, Dr. Reddy's, Sun Pharma, Adani Ports and Jio Financial Services
By Aman Shukla Published on June 16, 2025, 15:40 IST Indian equity markets closed on a strong note on June 16, 2025, with broad-based gains across major sectors. The BSE Sensex surged 677.55 points (0.84%) to close at 81,796.15, while the NSE Nifty 50 gained 227.90 points (0.92%) to end at 24,946.50—just shy of the key psychological level of 25,000. Despite the market's overall bullish trend, several heavyweight stocks saw significant declines during the session. Among the biggest losers of the day were well-known names like Tata Motors, Dr. Reddy's Laboratories and Sun Pharmaceutical. Let's take a closer look at the top losers of the Nifty 50, according to Trendlyne. Nifty 50 top losers on June 16 Tata Motors closed at ₹685.3, registering the steepest decline of 3.8% among major stocks. Dr. Reddy's Laboratories ended the session at ₹1,350, down by 0.9% . Sun Pharmaceutical slipped 0.5% , closing at ₹1,679. Adani Ports declined 0.3% , finishing at ₹1,400.2. Jio Financial Services remained unchanged, ending flat at ₹294. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Upturn
12-06-2025
- Business
- Business Upturn
Nomura upbeat on Dr. Reddy's long-term prospects; maintains ‘Buy' call with Rs 1,575 target
By Markets Desk Published on June 12, 2025, 07:38 IST Nomura has maintained its Buy rating on Dr. Reddy's Laboratories, setting a target price of ₹1,575, following the company's strategic roadmap shared during a recent management interaction. The company laid out four key levers to sustain growth and profitability beyond the gRevlimid opportunity, including: Sustained growth in the base business, Significant upside potential from semaglutide, the blockbuster diabetes and weight-loss drug, Capacity to undertake selective acquisitions in the $2–2.5 billion range, and A strong focus on cost rationalisation, with plans to reduce operating expenses by 500 basis points — from 37% to 32% of sales — thereby maintaining EBITDA margins around 25%. Dr. Reddy's, a major Indian pharmaceutical company with a strong global presence, has expanded its footprint across generics, biosimilars, and active pharmaceutical ingredients (APIs). It has also been building its presence in high-value markets like the US, Europe, and emerging markets through a mix of organic growth and strategic deals. Nomura believes the combination of margin optimisation, pipeline monetisation (including complex generics like semaglutide), and balance sheet flexibility places the company in a strong position for long-term value creation. Disclaimer: The views and target prices mentioned are as stated by Nomura and do not represent the opinions or recommendations of this publication. Investors are advised to consult their financial advisors before making any investment decisions. Markets Desk at
Business Upturn
10-06-2025
- Business
- Business Upturn
Nifty 50 top gainers today, June 10: Grasim Industries, Tech Mahindra, Dr. Reddy's Laboratories, Tata Motors and more
By Aman Shukla Published on June 10, 2025, 15:39 IST The Indian stock market witnessed a mixed trading session on June 10, with benchmark indices closing nearly flat amid volatility. At close, the Sensex was down 53.49 points or 0.06 percent at 82,391.72, and the Nifty was up 1.05 points at 25,104.25. Despite the subdued broader market, several Nifty 50 stocks posted strong gains, led by Grasim Industries, Tech Mahindra and Dr. Reddy's Laboratories. Below is a detailed look at the top gainers of the Nifty 50 (as per Trendline) for the day. Nifty 50 Top Gainers on June 10 Grasim Industries rose 3.7% to close at ₹2,704 . Tech Mahindra gained 2.1% , ending at ₹1,612.90 . Dr. Reddy's Laboratories climbed 2.1% , closing at ₹1,346.80 . Tata Motors advanced 2% , settling at ₹732.30 . Infosys increased by 1.5% , finishing at ₹1,596 . Adani Enterprises moved up 1.4% to ₹2,618 . HCL Technologies and Wipro both rose 1.4% , closing at ₹1,670.70 and ₹254.70 , respectively. Bharat Electronics edged up 1.3% to ₹397.40 . Tata Consultancy Services (TCS) saw a 1.2% gain, ending at ₹3,462.90. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
